Systemic inflammatory response and survival in patients with localised prostate cancer: 10-Year follow-up

Urologia Internationalis

Volumn 85, Issue 4, 2010, Pages 482-

  McArdle, Peter A ^a   Qayyum, Tahir ^a   McMillan, Donald C ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

BLADDER CANCER; BLOOD SAMPLING; BREAST CANCER; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; INFLAMMATION; KIDNEY CANCER; LETTER; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER;

C-REACTIVE PROTEIN; HUMANS; INFLAMMATION MEDIATORS; MALE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; RESEARCH DESIGN; SURVIVAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 78650984578     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320242     Document Type: Letter

References (5)

1. Dahm P: Editorial comment: A tale too good to be true. Urol Int 2010;84:434-435.
2. Bill-Axelson A, Holmberg L, Filén F, Ruutu M, Garmo H, Busch C, Nordling S, Häggman M, Andersson SO, Bratell S, Spång - berg A, Palmgren J, Adami HO, Johansson JE: Scandinavian radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst 2008; 100: 1144-1154.
3. McMillan DC: Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 2009; 12: 223-226.
4. Vasto S, Carruba G, Candore G, Italiano E, Di Bona D, Caruso C: Inflammation and prostate cancer. Future Oncol 2008; 4: 637-645.
5. Roxburgh CS, McMillan DC: Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 2010; 6: 149-163.